Search Results - "Spanedda, R"

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study by RICCARDI, A, MORA, O, DELFINI, C, NICOLETTI, G, BERGONZI, C, RINALDI, E, PICCININI, L, ASCARI, E, TINELLI, C, VALENTINI, D, BRUGNATELLI, S, SPANEDDA, R, DE PAOLI, A, BARBARANO, L, DI STASI, M, GIORDANO, M

“…We conducted a randomized trial to evaluate whether melphalan-prednisone (MPH-P) treatment administered just after diagnosis improves survival of stage I…”
Get full text

A case of disseminated Langerhans’ cell histiocytosis treated with thalidomide by Mauro, E., Fraulini, C., Rigolin, G. M., Galeotti, R., Spanedda, R., Castoldi, G.

“…:  Tumor necrosis factor alpha (TNF‐α) seems to play a key role in the pathogenesis of Langerhans’ cell histiocytosis (LCH). Thalidomide is an immunomodulator…”
Get full text

In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation by LANZA, F, CAMPIONI, D, PUNTURIERI, M, MORETTI, S, DABUSTI, M, SPANEDDA, R, CASTOLDI, G

“…The distribution and functional characteristics of in vitro bone marrow (BM) endothelial colonies (CFU-En) were studied in 70 non-Hodgkin's lymphoma (NHL)…”
Get full text

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol by Riccardi, A, Mora, O, Tinelli, C, Porta, C, Danova, M, Brugnatelli, S, Grasso, D, Tolcà, B, Spanedda, R, De Paoli, A, Barbarano, L, Cavanna, L, Giordano, M, Delfini, C, Nicoletti, G, Bergonzi, C, Rinaldi, E, Piccinini, L, Ascari, E

“…In this study we evaluated whether a good response to conventional chemotherapy, i.e. a significant tumour reduction, is a prerequisite for improved survival…”
Get full text

Chromosome aberrations in atypical chronic lymphocytic leukemia : a cytogenetic and interphase cytogenetic study by BIGONI, R, CUNEO, A, VERONESE, M. I, CROCE, C. M, CASTOLDI, G, ROBERTI, M. G, BARDI, A, RIGOLIN, G. M, PIVA, N, SCAPOLI, G, SPANEDDA, R, NEGRINI, M, BULLRICH, F

“…To define better the chromosomal profile of atypical chronic lymphocytic leukemia (aCLL), cytogenetic and interphase cytogenetic studies were performed in 43…”
Get full text

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol by RICCARDI, A, MORA, O, DELFINI, C, NICOLETTI, G, RINALDI, E, PICCININI, L, VALENTINI, D, ASCARI, E, BRUGNATELLI, S, TINELLI, C, SPANEDDA, R, DE PAOLI, A, BARBARANO, L, DI STASI, M, BERGONZI, C, GIORDANO, M

Get full text

Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy by RICCARDI, A, UCCI, G, DELFINI, C, NICOLETTI, G, MORANDI, S, RINALDI, E, PICCININI, L, DE PASQUALE, A, ASCARI, E, LUONI, R, BRUGNATELLI, S, MORA, O, SPANEDDA, R, DE PAOLI, A, BARBARANO, L, DI STASI, M, ALBERIO, F

Get full text

Primary gastric lymphoma: distribution and clinical relevance of different epidemiological factors by Fagioli, F, Rigolin, GM, Cuneo, A, Scapoli, G, Spanedda, R, Cavazzini, P, Castoldi, G

“…Institute of Hematology, University of Ferrara, Italy. BACKGROUND. Over the last 10 years the incidence of primary gastric lymphomas (PGL), and in particular…”
Get full text

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma by Riccardi, A, Mora, O, Brugnatelli, S, Tinelli, C, Spanedda, R, De Paoli, A, Barbarano, L, Di Stasi, M, Bergonzi, C, Giordano, M, Delfini, C, Nicoletti, G, Rinaldi, E, Piccinini, L, Valentini, D, Ascari, E

“…Age could influence the prognosis of multiple myeloma patients treated with conventional chemotherapy. Between January 1987 and March 1990, 341 consecutive…”
Get full text

Study of prognosis in acute myeloid leukemias (AML) by cluster analysis by Rigolin, GM, Fagioli, F, Spanedda, R, Scapoli, G, Lanza, F, Cuneo, A, Tomasi, P, Castoldi, G

“…Institute of Hematology, University of Ferrara, Italy. BACKGROUND. Cluster analysis is particularly effective in detecting homogeneous subgroups among large…”
Get full text

An unusual case of untreated chronic lymphocytic leukemia patient presenting with Rhodococcus equi bacteriemia by Matteo Rigolin, Gian, Bigoni, Renato, Spanedda, Romedio, Castoldi, Gianluigi, Rossi, Maria Rita

Get full text

Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cystostatic policy. Cooperative Group of Study and Treatment of Multiple Myeloma by Riccardi, A, Ucci, G, Luoni, R, Brugnatelli, S, Mora, O, Spanedda, R, De Paoli, A, Barbarano, L, Di Stasi, M, Alberio, F

“…The purpose of the study was to ascertain whether the prognostic significance of staging in multiple myeloma (MM) is influenced by the aggressiveness of…”
Get full text

Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease by Cuneo, A, Balboni, M, Piva, N, Carli, MG, Tomasi, P, Previati, R, Negrini, M, Scapoli, G, Spanedda, R, Castoldi, G

“…Institute of Hematology, University of Ferrara, Italy. Philadelphia chromosome-positive acute leukemias (Ph+ AL) show variable cytologic features, possibly…”
Get full text

Cytomorphological aspects of iron-containing plasma cells in hematological disorders by Tomasi, P, Lucchi, T, Ferrari, L, Scapoli, G, Spanedda, R, Castoldi, G

Get more information

The value and limitations of total body scan in the diagnosis of multiple myeloma: a comparison with conventional skeletal radiography by Scutellari, P N, Spanedda, R, Feggi, L M, Cervi, P M

Get more information

Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases by Cuneo, A, Lanza, F, Spanedda, R, Tomasi, P, Ferrari, L, Castoldi, G L

“…Three patients affected by T helper chronic lymphocytic leukemia were treated with low dose interferon alpha-2b (3 MU/m2 3 times weekly). The disease presented…”
Get more information

Automated assessment of lymphoid cells in chronic lymphocytic leukemia: correlation with prognostic features by Lanza, F, Scapoli, G L, Spanedda, R, Franzé, D, Castoldi, G L

Get more information

Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings by Rigolin, Gian Matteo, Cuneo, Antonio, Roberti, Maria Grazia, Bardi, Antonella, Bigoni, Renato, Piva, Nadia, Minotto, Claudia, Agostini, Paola, De Angeli, Cristiano, Del Senno, Laura, Spanedda, Romedio, Castoldi, Gianluigi

“…To better define the role of exposure to myelotoxic agents in the genesis of myelodysplastic syndrome (MDS), we carried out (a) a case–control study for the…”
Get full text

Non-hodgkin's lymphomas of extranodal localization. Strategies for imaging diagnosis by Scutellari, P N, Borgatti, L, Spanedda, R

“…To evaluate the diagnostic workup proposed by the UICC (International Union against Cancer) Flow charts for diagnosis and staging of lymphomas in developed and…”
Get more information

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma by Riccardi, A, Mora, O, Tinelli, C, Porta, C, Danova, M, Brugnatelli, S, Grasso, D, Tolcà, B, Spanedda, R, De Paoli, A, Barbarano, L, Cavanna, L, Giordano, M, Delfini, C, Nicoletti, G, Bergonzi, C, Rinaldi, E, Piccinini, L, Ascari, E

Get full text